Search Tag: SARS-CoV-2
Precision Medicine and COVID-19
2021 18 May
Precision medicine has been an important goal in healthcare. Researchers have been focused on generating new disease subclassifications to maximise individualised treatment options. There have been many phenotypes, endotypes, and subtypes so that patients who demonstrate specific symptoms and fall into a specific subtype or phenotype can be treated... Read more
Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech
2021 19 Jan
Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million... Read more
`Molecular Tests are Pivotal in Combating the COVID-19 Pandemic`
2020 28 Oct
The central laboratory of the Niels-Stensen-Kliniken group in Osnabrück wasted no time in setting up its own test facilities for the molecular detection of SARS-CoV-2. We spoke with Michael Erren, MD, Head of the Institute for Laboratory Medicine about his strategy and the importance of diagnostic molecular testing in fighting the pandemic.... Read more
J&J’s Vaccine Trial Paused
2020 13 Oct
Johnson & Johnson has announced temporarily pausing the COVID-19 vaccine candidate trials due to an unexplained illness in a study participant. You might also like: Rushing COVID-19 Vaccine Development: Is It Justified? As reported by STAT News, the company has informed external researchers through a document that a “passing... Read more
FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay
2020 06 Oct
Hologic, Inc. announced today that its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in May, is now authorized for testing of individuals without symptoms or other reasons to suspect COVID-19 infection. This authorization follows an announcement last week... Read more
How Exposure to SARS-CoV-2 Varies Across Hospital Settings
2020 24 Sep
New research from the UK has detected SARS-CoV-2 seroconversion among asymptomatic healthcare workers. Moreover, researchers were able to identify variation in the occupational risk of exposure to the pathogen – which causes COVID-19 – between hospital departments. You might also like: COVID-19: Risk Factors for Healthcare Workers... Read more
Siemens Healthineers Collaboration With CDC To Standardize SARS-CoV-2 Assays
2020 15 Sep
The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level... Read more
Siemens Healthineers Collaboration With CDC To Standardize SARS-CoV-2 Assays
2020 15 Sep
The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level... Read more
Hologic Launches Validated Pooling Protocol for COVID-19 Testing
2020 11 Aug
In Time of Extraordinary Need, New Protocol Expected to Help Laboratories Deliver Greater Quantities of Highly Accurate Molecular Test Results and Reduce Turnaround Times Hologic, Inc. announced today that it has validated use of its Aptima® and Panther Fusion® molecular diagnostic COVID-19 assays with pooled patient samples and completed... Read more